ASTEX PHARMACEUTICALS, INC — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dfa9830e-1c51-4204-8239-58b0ee330dcd/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2012 | $83.2M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-002974 |
| FY 2011 | $66.9M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-002753 |
| FY 2010 | $53.0M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-002753 |
| FY 2009 | $41.3M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-002753 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).